First Time Loading...

Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 2.25 USD -3.02% Market Closed
Updated: May 29, 2024

Entera Bio Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Entera Bio Ltd
Total Current Assets Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Entera Bio Ltd
NASDAQ:ENTX
Total Current Assets
$11.3m
CAGR 3-Years
7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Total Current Assets
$28m
CAGR 3-Years
70%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Total Current Assets
$157.8m
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
3%
B
BioLine RX Ltd
TASE:BLRX
Total Current Assets
$47.2m
CAGR 3-Years
27%
CAGR 5-Years
8%
CAGR 10-Years
10%
Urogen Pharma Ltd
NASDAQ:URGN
Total Current Assets
$196.8m
CAGR 3-Years
28%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Total Current Assets
₪26.4m
CAGR 3-Years
16%
CAGR 5-Years
24%
CAGR 10-Years
15%

See Also

What is Entera Bio Ltd's Total Current Assets?
Total Current Assets
11.3m USD

Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Total Current Assets amounts to 11.3m USD.

What is Entera Bio Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-2%

Over the last year, the Total Current Assets growth was -12%. The average annual Total Current Assets growth rates for Entera Bio Ltd have been 7% over the past three years , -2% over the past five years .